DS Stage II Plasma Cell Myeloma Completed Phase 2 Trials for Clarithromycin (DB01211)

IndicationStatusPhase
DBCOND0030429 (DS Stage II Plasma Cell Myeloma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00445692Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple MyelomaTreatment